TY - JOUR
T1 - Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.
JO - Pharmacoeconomics
PY - 2012/10/12
AU - Whyte S
AU - Pandor A
AU - Stevenson M
ED -
DO - DOI: 10.2165/11597210-000000000-00000
VL - 30
IS - 12
SP - 1119
EP - 1132
Y2 - 2025/07/29
ER -